Highlights
NASDAQ: RIGL       Rigel Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
2.23   -0.03 (1.33%)  2.20 - 2.36  1,218,396

Overview

 
Avg Volume (4 weeks):1,245,978
4 Weeks Range:2.03 - 2.45
4 Weeks Price Volatility (%):
47.62%
52 Weeks Range:1.56 - 2.90
52 Weeks Price Volatility (%):
50.00%
Average Price Target: 10.00
Price Target Upside/Downside: +7.77

Headlines



No recent Headlines for this stock.


Business Background

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken over all responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes Fostamatinib - ITP, Fostamatinib - AIHA, Fostamatinib - IgAN, BGB324 - Oral AXL Inhibitor, ATI-50001 & 50002 - JAK Inhibitors, DS-3032-MDM2 Inhibitor, THF-beta Inhibitors and AZD0449- Inhaled JAK Inhibitor.

  Be the first to like this.
 


 

2699  3027  332  2909 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AMD 41.15-1.44 
 CHK 0.784+0.002 
 DHR 148.62-2.68 
 GE 11.345-0.095 
 AABA 19.630.00 
 BAC 34.45-0.23 
 VIAB 24.22+0.75 
 NIO 2.40+0.13 
 AAPL 275.15+3.69 
Partners & Brokers